Canada markets close in 1 hour 10 minutes

Cronos Group Inc. (CRON)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
5.36-0.12 (-2.22%)
As of 2:50PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close5.48
Open5.47
Bid5.34 x 3200
Ask5.35 x 3000
Day's Range5.34 - 5.54
52 Week Range5.17 - 15.83
Volume1,407,548
Avg. Volume1,817,120
Market Cap1.995B
Beta (5Y Monthly)1.54
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
  • GlobeNewswire

    Cronos Group Launches its First Cultured Cannabinoid Product, SPINACH FEELZ™ Chill Bliss 2:1 THC|CBG Gummy

    SPINACH FEELZ™ Chill Bliss 2:1 THC|CBG Gummy Cronos Group unveils its new CBG product, the SPINACH FEELZ™ Chill Bliss 2:1 THC|CBG gummy, made using fermentation and proprietary methods to produce CBG without using the cannabis plant. Cronos Group unveils its new CBG product, the SPINACH FEELZ™ Chill Bliss 2:1 THC|CBG gummy, made using fermentation and proprietary methods to produce CBG without using the cannabis plantThe SPINACH FEELZ™ platform’s latest product innovation, the Chill Bliss gummy,

  • GlobeNewswire

    Cronos Group and Ginkgo Bioworks Announce Achievement of Equity Milestone in Partnership to Produce Cultured Cannabinoids

    By achieving commercial scale production of CBG, the companies are on track to enable access to rare cannabis moleculesTORONTO and BOSTON, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Cronos Group, Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group"), an innovative global cannabinoid company, and Ginkgo Bioworks (“Ginkgo”), which is building the leading horizontal platform for cell programming, today announced the achievement of the first target productivity milestone in their partnership to produce eight cult

  • GlobeNewswire

    Cronos Group Appoints Bob Madore as Chief Financial Officer

    TORONTO, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced the appointment of Bob Madore as Chief Financial Officer, effective August 9, 2021, who will succeed Jerry Barbato. “We are pleased to add a leader of Bob’s caliber to the Cronos Group team,” said Kurt Schmidt, President and Chief Executive Officer of Cronos Group. “Bob brings to Cronos Group a proven track record of